期刊文献+

中、美、日三国政府医药研发投入管理比较研究 被引量:2

A Comparative Research on the Pharmaceutical R&D Fund Management in China, USA and Japan
下载PDF
导出
摘要 从投入总量、投入形式、监管方式和运作方式四个角度,对比并分析了中、美、日三国政府医药研发经费管理情况。借鉴发达国家的政府医药研发投入管理经验,提出我国需加大医药研发投入力度、实行科研经费分开拨付、强化监督机制及加强医药成果转化等符合我国国情和医药产业发展状况的合理化建议。
作者 孙燕 孙利华
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2010年第6期472-476,共5页 Chinese Journal of Pharmaceuticals
  • 相关文献

参考文献14

二级参考文献20

  • 1戴国庆.美国联邦政府科研经费监督管理及其启示[J].科研管理,2006,27(1):17-22. 被引量:64
  • 2[1]薛澜,胡钰.中国科技发展的国际比较及政策建议[N].科技日报,2003-05-14(3).
  • 3[4]蒋丹平.发挥财政资金引导作用建科技投入机制[R].南京:东南大学,2005.
  • 4DIRECTOR'S STATUS REPORT , National Institute on Aging (September 2001 ). http:∥www. nia. nih. gov/naca/meetings/2001/september/status-report-sep2001. htm.
  • 5DIRECTOR'S STATUS REPORT TO COUNCIL, National Institute on Aging ( October 2000 ). http:∥www. nia. nih. gov/naca/meetings/2000/Sept/status- reports. htm #b&a.
  • 6Government Performance and Results Act (GPRA)Final FY 2001GPRA Annual Performance Plan,Revised Final FY 2000 GPRA Annual Performance Plan and FY 1999 GPRA Annual Performance Report. http:∥www1. od. nih. gov/gpra/fy2001. pdf.
  • 7Division of Extramural Activities, Annual Report 2001. http:∥deainfo. nci. nih. gov/DEArptFY2001. pdf.
  • 8Guide to Research and Training Programs. http:∥www. nia. nih.gov/news/2001guide. pdf.
  • 9Research Grants. http:∥grants2. nih. gov/grants/award/resgr.htm.
  • 10National Institutes of Health: Summary of the FY 2005 President's Budget. http:∥www. nih. gov/news/budget/FY2005presbudget.pdf.

共引文献45

同被引文献24

  • 1金泉源,黄泰康.中国、美国、日本医药产业创新体系的对比研究[J].中国药业,2005,14(10):2-3. 被引量:8
  • 2郝凤霞.基于创新网络的美国生物医药产业研究[J].科学学研究,2005,23(B12):288-291. 被引量:8
  • 3杨舒杰,陈晶.美国医药物流对我国的启示[J].中国药业,2007,16(20):5-5. 被引量:12
  • 4Son W K. Understanding the role of business services and growth: issues in modeling regional patterns [J]. Annals of Regional Science, 2007,41 ( 1 ) : 71-86.
  • 5Hauknes J, Knell M. Embodied knowledge and sectoral link- ages: An input-output approach to the interaction of high- and low-tech industries [ J ]. Research Policy, 2009,38 (3) : 459-469.
  • 6Arnold J M, Javorcik B S, Mattoo A. Does Services Liberal- ization Benefit Manufacturing Firms? Evidence from the Czech Republic [J]. Social Science Electronic Publishing, 2011,85(1) : 136-146.
  • 7Dimasi J A, Grabowski H G. The cost of biopharmaceutical R&D: is biotech different? [J]. Managerial & Decision Eco- nomics, 2007,28 (4/5) : 469-479.
  • 8Shah N. Pharmaceutical supply chains: key issues and strat- egies for optimization [J]. Computers & Chemical Engineer- ing, 2004,28 (6/7) : 929-941.
  • 9Sinha K K, Kohnke E J. Health Care Supply Chain Design: Toward Linking the Development and Delivery of Care Glob- ally[J]. Decision Sciences,2009,40(2) : 197-212.
  • 10Hill E W, Brennan J F. A Methodology for Identifying the Drivers of Industrial Clusters: The Foundation of Regional Competitive Advantage [J]. Economic Development Quar- terly, 2000,14( 1 ) : 65-96.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部